Rethinking Clinical Trials

JANUARY 31, 2024

DIHI approaches this work through four pillars of innovation: implementation and health delivery science, health technology innovation, leadership and workforce development, and best practices development and dissemination. We have continued to see the digital divide, where a small number of teams have expertise.

Production 161

Production Development Clinical Trials Clinical Trials 161

Rethinking Clinical Trials

OCTOBER 18, 2023

Speaker Keith Marsolo, PhD Associate Professor Department of Population Health Sciences Duke University School of Medicine Slides Keywords PCORnet, Common Data Model, EHR, Social Determinants of Health Key Points There are many different definitions of social determinants of health.

Clinical Trials 117

Clinical Trials Clinical Trials Clinical Research Research 117

Rethinking Clinical Trials

FEBRUARY 28, 2024

from 2021 to 2026. Consider secure digital identification, two-fact authentication or virtual/video visits. Outcomes including patient reported outcomes, functional assessments including via digital technology, healthcare events or mortality may require identify verification. Balance with not adding barriers for participation.

Clinical Trials 141

Clinical Trials Clinical Trials Trials Clinical Research 141

Rethinking Clinical Trials

JANUARY 17, 2024

The COVID Therapeutics Committee worked with the state health department to develop a policy for fair allocation of scarce medications to treat COVID-19. When Evusheld was approved in December 2021 a similar weighted lottery process was put into place. We know there is a digital gap in disadvantaged patients and elderly patients.

Clinical Trials 169

Clinical Trials Clinical Trials Antibody Trials 169

pharmaphorum

NOVEMBER 24, 2021

Digital health company Pear Therapeutics has won FDA breakthrough device status for reSET-A, its development-stage prescription digital therapeutic (DTx) for people with alcohol-use disorder. The post Pear claims breakthrough tag for alcohol use disorder DTx appeared first on. Photo by thom masat on Unsplash.

Production 57

Production Development Trials 57

Rethinking Clinical Trials

AUGUST 23, 2022

Associate Professor, Global Health. It was held virtually on April 28-29, 2021. ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?. Speakers. Gerald Bloomfield, MD, MPH. Associate Professor with Tenure, Medicine. Duke University School of Medicine. Michelle Kelsey, MD. Assistant Professor of Medicine. Diversity, Inclusion.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Medicine 130

The Pharma Data

NOVEMBER 29, 2021

On 26 November 2021, WHO designated the variant B.1.1.529 1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). They should increase some public health and medical capacities to manage an increase in cases. Recommended actions for countries.

Vaccination 52

Vaccination Vaccine Genome Genomics 52